Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial-Reference-Cited by-同舟云学术

Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial

Published:2001-12 Issue: Volume:34 Page:65-69
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Frasci Giuseppe,Lorusso Vito,Panza Nicola,Comella Pasquale,Nicolella Gianpaolo,Bianco Andrea,DeCataldis Giuseppe,Belli Mario,Iannelli Nunzio,Massidda Bruno,Mascia Vittorio,Comella Giuseppe,De Lena Mario

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference11 articles.

1. The national cancer data base report on lung cancer;Fry;Cancer,1997

2. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer;J. Natl. Cancer Inst.,1999

3. Activity of gemcitabine in patients with non-small cell lung cancer;Gatzmeier;Eur. J. Cancer,1996

4. Single agent gemcitabine activity in non-small cell lung cancer;Shepherd;Lung Cancer,1997

5. Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small cell lung cancer;Lorusso;J. Clin. Oncol.,2000

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the interplay between dNTP metabolism and genome stability in cancer;Disease Models & Mechanisms;2024-08-01

2. Clinical use of biomarkers in the field of cytotoxic nucleoside analogues;Nucleosides, Nucleotides & Nucleic Acids;2023-10-24

3. Are clinical trial eligibility criteria representative of older patients with lung cancer? A population-based data linkage study;Journal of Geriatric Oncology;2021-07

4. Cancer in Older Adults;Principles and Practice of Geriatric Surgery;2020

5. Efficacy of Vinorelbine Monotherapy as Third- or Further-Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer;Oncology;2019